
Epigral Ltd is Rated Sell
2026-11-13 10:10:45Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Epigral Ltd Surges 7.77% to Day's High of Rs 951 — Outperforms Sector by 5.4 Percentage Points
2026-11-11 10:32:31The Sensex advanced 1.49% on 11 Nov 2026, yet Epigral Ltd outpaced the broader market with a 7.77% gain, touching an intraday high of Rs 951. This 5.4 percentage-point outperformance over its Specialty Chemicals sector peers signals a distinctly stock-specific rally rather than a mere market tailwind.
Read More
Epigral Ltd Surges 8.64% to Day's High of Rs 942.65 — Outperforms Sector by 6.98 Percentage Points
2026-11-02 14:31:59The Sensex advanced 0.98% on 2 Nov 2026, yet Epigral Ltd outpaced the broader market with an 8.64% gain, reaching an intraday high of Rs 942.65. This 6.98-percentage-point outperformance over its Specialty Chemicals sector peers marks a notable single-session surge that rewrites the short-term narrative for this small-cap stock.
Read More
Epigral Ltd is Rated Sell by MarketsMOJO
2026-11-01 10:10:05Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 01 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read MoreEpigral Ltd Falls 2.62% Amid Bearish Technical Signals and Underperformance
2026-10-31 12:02:06Key Events This Week 26 Oct: Stock opens at Rs.887.40, down 1.15% amid broader market gains 27 Oct: Price rebounds to Rs.898.35 (+1.23%) following technical signals 29 Oct: Death Cross formation confirmed, signalling bearish trend 30 Oct: MarketsMOJO grade downgraded to Sell; stock closes at Rs.874.15 (-3.25%) Week OpenRs.897.70 <div class="stat-l...
Read More
Epigral Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-10-30 08:02:36Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a marked shift in its technical momentum, with key indicators signalling a bearish trend. The company’s stock price currently hovers near ₹903.50, reflecting a subtle decline amid broader market pressures and deteriorating technical signals.
Read More
Epigral Ltd Forms Death Cross, Signalling Potential Bearish Trend
2026-10-29 18:01:12Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and long-term weakness in the stock’s price trajectory.
Read More
Epigral Ltd is Rated Sell by MarketsMOJO
2026-10-21 10:10:19Epigral Ltd is currently rated 'Sell' by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics discussed here reflect the stock's present position as of 21 October 2026, providing investors with the most recent and relevant data to assess the company’s outlook.
Read More
Epigral Ltd is Rated Sell by MarketsMOJO
2026-10-10 10:10:20Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 October 2026, providing investors with the most up-to-date view of the company’s performance and outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
17-Nov-2026 | Source : BSEOne-on-One Meeting through Video Conferencing (V.C.) with Kitara Capital on Friday 20th November 2026.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
17-Nov-2026 | Source : BSEOne-on-One Meeting through Video Conferencing (V.C.) with Kotak Mahindra Asset Management (Singapore) Pte Ltd on Thursday 19th November 2026.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
07-Nov-2026 | Source : BSEEpigral Limited submits Transcript of conference call held on Monday 2nd November 2026 discussing Q2 FY2027 Results.
Corporate Actions
No Upcoming Board Meetings
Epigral Ltd has declared 50% dividend, ex-date: 01 Jun 26
No Splits history available
No Bonus history available
No Rights history available